Navigation Links
Ferring Pharmaceuticals and RESOLVE: The National Infertility Association Join Together to Launch Nurse Liaison Program
Date:4/27/2009

Program to Launch During RESOLVE's National Infertility Awareness Week(R), April 25 - May 2 Across the Country

PARSIPPANY, N.J., April 27 /PRNewswire/ -- Ferring Pharmaceuticals, which offers the broadest portfolio of fertility treatments in the U.S., has partnered with leading patient advocate organization, RESOLVE: The National Infertility Association, to launch the RESOLVE Nurse Liaison Program during National Infertility Awareness Week(R) (NIAW), April 25-May 2. The program was developed to create a network of nurses from every Society for Assisted Reproductive Technology (SART) member infertility center in the United States to serve as RESOLVE ambassadors in their medical practice. Since nurses play a crucial role in the patient care process, the program was designed to arm them with relevant information about treatment options and valuable educational materials for infertility patients.

Nurses who enroll in the RESOLVE Nurse Liaison Program will receive e-communication on a regular basis with up-to-date patient education materials and other available resources. In addition, RESOLVE will periodically ask for feedback from nurses on the current state of patient education in infertility and gaps that they see in patient's knowledge. As a member of this valuable program, nurses will be prominently featured on RESOLVE's Web site and have the opportunity to contribute articles and speak at RESOLVE events.

"RESOLVE is proud to collaborate with Ferring Pharmaceuticals especially during National Infertility Awareness Week(R). Our goal is to spread information about infertility and its treatments to those fighting the disease of infertility," said Barbara Collura, RESOLVE's executive director. "We are thrilled to be partnering with a leader in the field of infertility who can help RESOLVE provide vital information to the nurses who are on the front lines of the patient care journey."

"Ferring is pleased to be working with RESOLVE to give nurses the resources they need to enhance the patient care journey," said Olivier Delannoy, vice president, Infertility Business Unit at Ferring. "As a leader in providing patients with access to affordable and user-friendly treatment options, Ferring remains committed to supporting the reproductive community with the tools they need to help simplify the patient treatment process."

Nurses who are interested in becoming a member of the RESOLVE Nurse Liaison Program can visit www.resolve.org/nurseprogram. Upon receipt of the registration form, RESOLVE will send a program welcome packet that outlines the details of the program.

About Ferring Pharmaceuticals

Ferring Pharmaceuticals, part of the Ferring Group, a privately owned, international pharmaceutical company, manufactures and markets the largest family of fertility treatments in the U.S. The Company markets MENOPUR, BRAVELLE, REPRONEX(R) (menotropins for injection, USP), NOVAREL(R) (chorionic gonadotropin for injection, USP) and ENDOMETRIN(R) (progesterone) Vaginal Insert in the U.S. to infertility specialists and their patients. Ferring also offers the Q-CAP(TM), the first and only needle-free reconstitution device, for use with its fertility treatments.

Ferring's line of orthopaedic and urology products includes EUFLEXXA(R) (1% sodium hyaluronic acid) and PROSED(R) DS (methenamine, phenyl salicylate, methylene blue, benzoic acid, hyoscyamine sulfate). Other products include: ACTHREL(R) (corticorelin ovine triflutate for injection), DESMOPRESSIN and DEGARELIX for injection.

The Ferring Group specializes in the research, development and commercialization of compounds in general and pediatric endocrinology, urology, gastroenterology, obstetrics/ gynecology, infertility and orthopaedics. For more information, call 888-337-7464 or visit www.ferringusa.com or www.ferringfertility.com.

About RESOLVE: The National Infertility Association

Founded in 1974, RESOLVE: The National Infertility Association, headquartered in McLean, VA, is the oldest and largest consumer-based, nonprofit group that provides education, advocacy and compassionate support for those struggling with infertility in the United States. Each year, RESOLVE and its nationwide network of affiliates handle more than 1.5 million contacts from people seeking information and help. For more information, visit the RESOLVE website at www.resolve.org.


'/>"/>
SOURCE Ferring Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Educating referring clinicians about advanced imaging leads to drop in imaging exams
2. Frost & Sullivan Accolade for Ferring Pharmaceuticals
3. Ferring Pharmaceuticals Announces Immediate Availability of Degarelix for the Treatment of Advanced Prostate Cancer
4. Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit
5. Dr. Jan Linhart Now Offerring Unique Laser Teeth Whitening System
6. Ferring Pharmaceuticals EUFLEXXA(R) to Serve as a Sponsor for the Babolat World Tennis Classic
7. Increase in Diagnostic Imaging Fueled by Self-Referring Doctors
8. Ferring Pharmaceuticals EUFLEXXA(TM) to Serve as Sponsor for Sprint Force America Masters Track Club
9. Ferring Announces $10,000 Grand Prize Winner of 2007 My Little Miracle Essay Contest
10. Medimetriks Pharmaceuticals Launches Two New Prescription Brands
11. PUR Water Filtration Systems Can Reduce Trace Levels of Pharmaceuticals Found in Some U.S. Tap Water
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... ... enables researchers to pursue the recent RNA methylation “gold rush” with their established ... of the newfound characteristics of N6-methyladenosine, or m6A , RNA methylation has ...
(Date:3/27/2017)... ... March 27, 2017 , ... The Association of Healthcare ... will hold their first Northeast Regional AHVAP Meeting. For 2017, Dr. Hayes will ... chain and value analysis professionals have a ‘seat at the table’ with clinical ...
(Date:3/27/2017)... ... ... According to the American Cancer Society , the average 15-year survival ... the cancer spreads to other organs, bones, or lymph nodes, however, the 5-year survival ... latter group, tune in to Lifestyle Magazine on April 9, 2017, to ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... sodium testing methods are complicated and require expert user knowledge. In a live ... method dedicated to the simplified, yet highly accurate, determination of sodium. , It ...
(Date:3/27/2017)... ... 27, 2017 , ... ?Grow Healthy Vending LLC announced today ... between itself and 1800 Vending DBA Healthy You Vending. (Civil No. 1:14-CV-00121-CW/ United ... announce that we have now reached a settlement agreement regarding the ongoing lawsuits ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... March 27, 2017 On Friday, ... NASDAQ Composite closed the trading session up 0.19%; the ... S&P 500 was down 0.08%. US markets made broad ... the day in green. Pre-market today, Stock-Callers.com reviews these ... N.V. (NASDAQ: WMGI), Amedica Corporation (NASDAQ: AMDA), MiMedx Group ...
(Date:3/27/2017)... March 27, 2017  Twist Bioscience, a company accelerating ... announced that it raised an additional $33 million. To ... million. "It is an exciting time ... reach and continue to deliver industry-leading gene volume to ... commented Emily M. Leproust, Ph.D., CEO of Twist Bioscience. ...
(Date:3/27/2017)... , March 27, 2017  PhaseRx, Inc. ... for life-threatening inherited liver diseases in children, today ... full year ended December 31, 2016 and provided ... "PhaseRx continued to make progress during the ... positive results from our non-human primate safety study, and ...
Breaking Medicine Technology: